Real‐world romiplostim dosing, response and home administration in paediatric immune thrombocytopenia

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Figure S1. Single platelet response to romiplostim by (A) disease phase and (B) bleeding score. Table S1. Clinical characteristics. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.